Loading...
Current status of PI3K-mTOR inhibition in hormone-receptor positive, HER2-negative breast cancer
Breast cancer (BC) is the most common cancer in women and second only to lung cancer in terms of mortality. Among the three different BC subtypes, the oestrogen receptor positive represents nearly 70% of all cases and it is usually treated with anti-oestrogen drugs. However, the majority of hormone...
Saved in:
| Published in: | World J Clin Oncol |
|---|---|
| Main Authors: | , , , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
Baishideng Publishing Group Inc
2018
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6314865/ https://ncbi.nlm.nih.gov/pubmed/30622925 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5306/wjco.v9.i8.172 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|